LiveASX is an independent website and is not affiliated with, endorsed by, or associated with ASX Limited.

Immuron Reports Quarterly Sales Growth And Cuts ATM Facility Capacity

Immuron Limited (IMC) · Health care

Closing price · 2026-10-27: $0.037 · -7.50%

Immuron reported quarterly sales of approximately A$2 million, up 9% on the prior-year period and 5% on the previous quarter, with Australian and Canadian sales rising while US sales declined. The company attributed Australian growth partly to Travelan’s relaunch and said US inventory has been replenished after customs and logistics delays. Separately, Immuron reduced the capacity of its existing at-the-market funding facility to approximately US$2 million, retaining discretion over whether and when to issue shares.

Based on IMC’s ASX announcements · Latest release 27/10/2026 01:06 PM Sydney time
Story updated: 27/10/2026 01:13 PM

Source announcements:

More news from 2026-10-27 · Company history